Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082228 | Drug Discovery Today: Disease Models | 2010 | 7 Pages |
Abstract
Pulmonary arterial hypertension (PAH) is more frequent in chronically HIV-infected patients. There is no animal model to study PAH associated with HIV. Non-human primates infected with SIV (simian homolog of HIV), or with chimeric virions (SIV/HIV, or SHIV), closely recapitulate HIV infection, immunodeficiency, and pulmonary arteriopathy seen in humans with PAH. Here we discuss the pros, cons, and promises in the emerging field focused on long-term complications of HIV infection.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Sharilyn Almodovar, Sonia C. Flores,